Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project

      Access to essential medications and health products is critical to effective management of kidney disease. Using data from the ISN Global Kidney Health Atlas multinational cross-sectional survey, global access of patients with kidney disease to essential medications and health products was examined. Overall, 125 countries participated, with 118 countries, composing 91.5% of the world’s population, providing data on this domain. Most countries were unable to access eGFR and albuminuria in their primary care settings. Only one-third of low-income countries (LICs) were able to measure serum creatinine and none were able to access eGFR or quantify proteinuria. The ability to monitor diabetes mellitus through serum glucose and glycated hemoglobin measurements was suboptimal. Pathology services were rarely available in tertiary care in LICs (12%) and lower middle-income countries (45%). While acute and chronic hemodialysis services were available in almost all countries, acute and chronic peritoneal dialysis services were rarely available in LICs (18% and 29%, respectively). Kidney transplantation was available in 79% of countries overall and in 12% of LICs. While over one-half of all countries publicly funded RRT and kidney medications with or without copayment, this was less common in LICs and lower middle-income countries. In conclusion, this study demonstrated significant gaps in services for kidney care and funding that were most apparent in LICs and lower middle-income countries.


      To read this article in full you will need to make a payment
      ISN Member Login
      ISN Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • O’Connell T.
        • Rasanathan K.
        • Chopra M.
        What does universal health coverage mean?.
        Lancet. 2014; 383: 277-279
      1. WHO. Universal health coverage: supporting country needs. Available at: Accessed August 5, 2017.

      2. WHO. Sustainable Development Goal 3: Health. 2016. Available at: Accessed August 5, 2017.

        • Tonelli M.
        • Wiebe N.
        • Culleton B.
        • et al.
        Chronic kidney disease and mortality risk: a systematic review.
        J Am Soc Nephrol. 2006; 17: 2034-2047
        • Radhakrishnan J.
        • Remuzzi G.
        • Saran R.
        • et al.
        Taming the chronic kidney disease epidemic: a global view of surveillance efforts.
        Kidney Int. 2014; 86: 246-250
        • Levey A.S.
        • Atkins R.
        • Coresh J.
        • et al.
        Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes.
        Kidney Int. 2007; 72: 247-259
        • Hill N.R.
        • Fatoba S.T.
        • Oke J.L.
        • et al.
        Global prevalence of chronic kidney disease: a systematic review and meta-analysis.
        PLoS One. 2016; 11e0158765
        • Sarnak M.J.
        • Levey A.S.
        • Schoolwerth A.C.
        • et al.
        Kidney disease as a risk factor for development of cardiovascular disease.
        Circulation. 2003; 108: 2154-2169
        • Herzog C.A.
        • Asinger R.W.
        • Berger A.K.
        • et al.
        Cardiovascular disease in chronic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
        Kidney Int. 2011; 80: 572-586
        • Gansevoort R.T.
        • Matsushita K.
        • van der Velde M.
        • et al.
        Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes: a collaborative meta-analysis of general and high-risk population cohorts.
        Kidney Int. 2011; 80: 93-104
        • Lameire N.H.
        • Bagga A.
        • Cruz D.
        • et al.
        Acute kidney injury: an increasing global concern.
        Lancet. 2013; 382: 170-179
        • Mehta R.L.
        • Burdmann E.A.
        • Cerdá J.
        • et al.
        Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study.
        Lancet. 2016; 387: 2017-2025
        • Chawla L.S.
        • Kimmel P.L.
        Acute kidney injury and chronic kidney disease: an integrated clinical syndrome.
        Kidney Int. 2012; 82: 516-524
      3. ISN. Regions. Available at: Accessed August 5, 2017.

      4. World Bank. World Bank country and lending groups—World Bank data help desk. Available at: Accessed August 25, 2017.

      5. World Bank. Health expenditure, total (% of GDP). December 2016. Available at: Accessed December 30, 2016.

        • Johnson D.W.
        • Atai E.
        • Chan M.
        • et al.
        KHA-CARI Guideline: early chronic kidney disease: detection, prevention and management: early chronic kidney disease guidelines.
        Nephrology. 2013; 18: 340-350
        • Wouters O.J.
        • O’Donoghue D.J.
        • Ritchie J.
        • et al.
        Early chronic kidney disease: diagnosis, management and models of care.
        Nat Rev Nephrol. 2015; 11: 491-502
        • Stevens P.E.
        • Levin A.
        Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.
        Ann Intern Med. 2013; 158: 825-830
        • Noble E.
        • Johnson D.W.
        • Gray N.
        • et al.
        The impact of automated eGFR reporting and education on nephrology service referrals.
        Nephrol Dial Transplant. 2008; 23: 3845-3850
        • Johnson D.W.
        • Jones G.R.D.
        • Mathew T.H.
        • et al.
        Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations.
        Med J Aust. 2012; 197: 224-225
      6. International Diabetes Foundation. IDF diabetes atlas. Available at: Accessed August 5, 2017.

        • Stratton I.M.
        • Adler A.I.
        • Neil H.A.W.
        • et al.
        Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
        BMJ. 2000; 321: 405-412
        • Karopadi A.N.
        • Mason G.
        • Rettore E.
        • Ronco C.
        Cost of peritoneal dialysis and haemodialysis across the world.
        Nephrol Dial Transplant. 2013; 28: 2553-2569
        • Kirchgessner J.
        • Perera-Chang M.
        • Klinkner G.
        • et al.
        Satisfaction with care in peritoneal dialysis patients.
        Kidney Int. 2006; 70: 1325-1331
        • Wang V.
        • Maciejewski M.L.
        • Coffman C.J.
        • et al.
        Impacts of geographic distance on peritoneal dialysis utilization: refining models of treatment selection.
        Health Serv Res. 2017; 52: 35-55
        • Johnson D.W.
        • Hayes B.
        • Gray N.A.
        • et al.
        Renal services disaster planning: lessons learnt from the 2011 Queensland floods and North Queensland cyclone experiences.
        Nephrology. 2013; 18: 41-46
        • Mehrotra R.
        • Devuyst O.
        • Davies S.J.
        • Johnson D.W.
        The current state of peritoneal dialysis.
        J Am Soc Nephrol. 2016; 27: 3238-3252
        • Li P.K.
        • Chow K.M.
        Peritoneal dialysis-first policy made successful: perspectives and actions.
        Am J Kidney Dis. 2013; 62: 993-1005
        • Tantivess S.
        • Werayingyong P.
        • Chuengsaman P.
        • Teerawattananon Y.
        Universal coverage of renal dialysis in Thailand: promise, progress, and prospects.
        BMJ. 2013; 346: f462
        • Sedor J.R.
        • Watnick S.
        • Patel U.D.
        • et al.
        ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities.
        J Am Soc Nephrol. 2010; 21: 1235-1237
        • Liu F.X.
        • Gao X.
        • Inglese G.
        • et al.
        A global overview of the impact of peritoneal dialysis first or favored policies: an opinion.
        Perit Dial Int. 2015; 35: 406-420
        • Teerawattananon Y.
        • Luz A.
        • Pilasant S.
        • et al.
        How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?.
        Heal Res Policy Syst. 2016; 14: 21
        • Feehally J.
        The International Society of Nephrology (ISN): roles and challenges in Africa and other resource-limited communities.
        Clin Nephrol. 2016; 86: 3-7
      7. ISN. PD for AKI: Saving Young Lives project. Available at: Accessed August 25, 2017.

        • Abdou N.
        • Antwi S.
        • Koffi L.A.
        • et al.
        Peritoneal dialysis to treat patients with acute kidney injury—the Saving Young Lives experience in West Africa: proceedings of the Saving Young Lives Session at the First International Conference of Dialysis in West Africa, Dakar, Senegal, December 2015.
        Perit Dial Int. 2017; 37: 155-158
        • Smoyer W.E.
        • Finkelstein F.O.
        • McCulloch M.I.
        • et al.
        “Saving Young Lives” with acute kidney injury: the challenge of acute dialysis in low-resource settings.
        Kidney Int. 2016; 89: 254-256
        • Wolfe R.A.
        • Ashby V.B.
        • Milford E.L.
        • et al.
        Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
        N Engl J Med. 1999; 341: 1725-1730
        • Ackoundou-N’Guessan C.
        • Hoang A.D.
        • Ben Abdallah T.
        • et al.
        Living kidney donor transplantation in a resource-limited country: the Ivory Coast experience.
        Transplant Proc. 2015; 47: 1580-1584
        • Lee B.X.
        • Kjaerulf F.
        • Turner S.
        • et al.
        Transforming our world: implementing the 2030 agenda through sustainable development goal indicators.
        J Public Health Policy. 2016; 37: 13-31
      8. WHO. WHO model lists of essential medicines. 2017. Available at: Accessed August 5, 2017.

        • Leowski J.
        • Krishnan A.
        Capacity to control noncommunicable diseases in the countries of South-East Asia.
        Health Policy. 2009; 92: 43-48
        • Bello A.K.
        • Levin A.
        • Tonelli M.
        • et al.
        Assessment of global kidney health care status.
        JAMA. 2017; 317: 1864
        • Bello A.K.
        • Johnson D.W.
        • Feehally J.
        • et al.
        Global Kidney Health Atlas (GKHA): design and methods.
        Kidney Int Suppl. 2017; 7: 145-153
      9. WHO. Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Available at: Accessed August 5, 2017.